NICOLE POWERS: Open Payments
NPI 1114588407 · CHARLOTTE COURT HOUSE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,970 in 101 payments from 8 companies in 2025. Trend: 2023 $613 · 2024 $2,365 · 2025 $1,970
Food & beverage: $1,970
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 17 | $454 |
| Otsuka America Pharmaceutical, Inc. | 14 | $452 |
| Neurocrine BioSciences, Inc. | 8 | $301 |
| Teva Pharmaceuticals USA, Inc. | 28 | $297 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $260 |
| Lundbeck LLC | 7 | $138 |
| ABBVIE INC. | 2 | $38 |
| Boston Scientific Corporation | 1 | $30 |
Products named: REXULTI, COBENFY, INGREZZA, CAPLYTA, AUSTEDO XR, UZEDY, ABILIFY ASIMTUFII, VRAYLAR.
Industry payments across VA — which companies pay providers there.
